Ladenburg Thalmann Financial Services’s Trillium Therapeutics Inc. TRIL Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$4K	Hold	3,500	–	–	﹤0.01%	4915
2019 Q3	$1K	Hold	3,500	–	–	﹤0.01%	5210
2019 Q2	$1K	Hold	3,500	–	–	﹤0.01%	5207
2019 Q1	$2K	Hold	3,500	–	–	﹤0.01%	4995
2018 Q4	$6K	Hold	3,500	–	–	﹤0.01%	4544
2018 Q3	$20K	Hold	3,500	–	–	﹤0.01%	3917
2018 Q2	$25K	Hold	3,500	–	–	﹤0.01%	3711
2018 Q1	$25K	Hold	3,500	–	–	﹤0.01%	3711
2017 Q4	$25K	Buy	+3,500	New	+$29K	﹤0.01%	3659
2015 Q4	–	Sell	-100	Closed	-$1K	–	4830
2015 Q3	$1K	Hold	100	–	–	﹤0.01%	4493
2015 Q2	$2K	Buy	+100	New	+$2.28K	﹤0.01%	4384

Other funds holding TRIL

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Ladenburg Thalmann Financial Services's TRIL Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Trillium Therapeutics Inc. (TRIL) position steady in Q4 2019 at 3,500 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4915.

Ladenburg Thalmann Financial Services first reported a position in TRIL in Q2 2015 and has held it in 11 quarters since. The position peaked at $25K in Q2 2018. 19 funds tracked by Wall St. Rank hold TRIL as of Q4 2019.

Ladenburg Thalmann Financial Services held 3,500 shares of Trillium Therapeutics Inc. worth $4K as of Q4 2019.
Ladenburg Thalmann Financial Services left its Trillium Therapeutics Inc. share count unchanged in Q4 2019.
Trillium Therapeutics Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4915 holding.
Ladenburg Thalmann Financial Services first reported a position in Trillium Therapeutics Inc. in Q2 2015 and has held it in 11 quarters since.
Ladenburg Thalmann Financial Services's Trillium Therapeutics Inc. position peaked at $25K in Q2 2018.
19 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.